MGC57346 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.5695890687748E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.68400000003055E-08 |
Normal-vs-Stage2 |
6.118700E-03 |
Normal-vs-Stage3 |
4.275200E-03 |
Normal-vs-Stage4 |
3.476200E-02 |
Stage1-vs-Stage2 |
5.383400E-01 |
Stage1-vs-Stage3 |
9.564400E-01 |
Stage1-vs-Stage4 |
2.647400E-01 |
Stage2-vs-Stage3 |
6.125600E-01 |
Stage2-vs-Stage4 |
3.693200E-01 |
Stage3-vs-Stage4 |
2.749400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.14972484258169E-12 |
Normal-vs-AfricanAmerican |
1.199990E-04 |
Normal-vs-Asian |
4.376500E-03 |
Caucasian-vs-AfricanAmerican |
8.007600E-02 |
Caucasian-vs-Asian |
5.801800E-01 |
AfricanAmerican-vs-Asian |
9.792800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.70219999101806E-09 |
Normal-vs-Female |
1.02880037822217E-10 |
Male-vs-Female |
1.615490E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.799800E-04 |
Normal-vs-Extreme_Weight |
9.59170000000009E-05 |
Normal-vs-Obese |
1.8952000002681E-07 |
Normal-vs-Extreme_Obese |
9.461600E-02 |
Normal_Weight-vs-Extreme_Weight |
5.646400E-01 |
Normal_Weight-vs-Obese |
4.095800E-01 |
Normal_Weight-vs-Extreme_Obese |
5.786400E-01 |
Extreme_Weight-vs-Obese |
1.067840E-01 |
Extreme_Weight-vs-Extreme_Obese |
8.058800E-01 |
Obese-vs-Extreme_Obese |
2.857400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.045200E-04 |
Normal-vs-Age(41-60Yrs) |
4.72022421149632E-12 |
Normal-vs-Age(61-80Yrs) |
2.30219999952652E-07 |
Normal-vs-Age(81-100Yrs) |
4.884600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.347000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.295600E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.262210E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.634200E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.852500E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.544150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.98274729967807E-12 |
Normal-VS-Type2 PRCC |
9.157800E-03 |
Normal-VS-KIRP CIMP |
1.896110E-02 |
Normal-VS-Unclassified PRCC |
3.798200E-04 |
Type1 PRCC-VS-Type2 PRCC |
7.385400E-04 |
Type1 PRCC-VS-KIRP CIMP |
2.556000E-01 |
Type1 PRCC-VS-Unclassified PRCC |
8.092600E-01 |
Type2 PRCC-VS-KIRP CIMP |
6.012200E-02 |
Type2 PRCC-VS-Unclassified PRCC |
3.475900E-02 |
KIRP CIMP-VS-Unclassified PRCC |
1.396000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.641100E-04 |
Normal-vs-N1 |
3.000900E-03 |
Normal-vs-N2 |
1.586360E-01 |
N0-vs-N1 |
5.111800E-02 |
N0-vs-N2 |
2.644000E-01 |
N1-vs-N2 |
6.226800E-01 |
|
|